SWOT Analysis for SMS Pharmaceuticals Ltd. - Weakness

Add SWOT widget to your site/app

Benjamin Graham Value Screen

Companies with 10% increase in share price over three months, with rising net profit growth

Consistent Highest Return Stocks over Five Years

Mid-range Performer (DVM)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing profits every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Promoters increased pledged shares QoQ

Declining Net Cash Flow : Companies not able to generate net cash

RSI indicating price weakness

High promoter stock pledges

Highest increase in pledges by promoters

Mutual Funds Increased Shareholding in Past Month

Big Deal (Insider and SAST) buys last month greater than 1% of total shares

Big Deal (Insider and SAST) buys last week greater than 1% of total shares

Companies with improving valuation scores after share price falls

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

MFs decreased their shareholding last quarter

Promoters increasing shareholding QoQ

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks